Cubist Systematic Strategies, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$753,697
-82.8%
23,836
-79.7%
0.01%
-77.8%
Q1 2023$4,375,312
-26.7%
117,395
-31.4%
0.03%
-22.9%
Q4 2022$5,971,458
+22.1%
171,151
+95.9%
0.04%
+29.6%
Q3 2022$4,889,000
+8.5%
87,367
+0.3%
0.03%
-3.6%
Q2 2022$4,508,000
+435.4%
87,088
+651.5%
0.03%
+300.0%
Q1 2022$842,000
-69.9%
11,589
-44.4%
0.01%
-80.0%
Q3 2021$2,794,000
-9.6%
20,830
+9.1%
0.04%0.0%
Q2 2021$3,092,000
+1536.0%
19,097
+710.6%
0.04%
+1650.0%
Q1 2021$189,000
-92.3%
2,356
-94.8%
0.00%
-94.1%
Q4 2020$2,457,000
+164.8%
45,163
-3.2%
0.03%
+142.9%
Q3 2020$928,000
-26.6%
46,658
-22.5%
0.01%
-36.4%
Q2 2020$1,265,000
+639.8%
60,199
+500.6%
0.02%
+266.7%
Q1 2019$171,000
-76.7%
10,023
-81.3%
0.01%
-82.9%
Q4 2018$733,000
+366.9%
53,669
+876.9%
0.04%
+288.9%
Q3 2018$157,000
-54.6%
5,494
-56.6%
0.01%
-47.1%
Q2 2018$346,000
+37.3%
12,653
+5.9%
0.02%
+13.3%
Q1 2018$252,00011,9440.02%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders